5-HT(1A) receptor and apoptosis contribute to interferon-α-induced "depressive-like" behavior in mice

Fengfeng Ping1, Jing Shang, Jia Zhou

  • 1Center for Drug Screening, China Pharmaceutical University, Nanjing 210009, China.

Neuroscience Letters
|March 15, 2012
PubMed

Insights

Interferon-alfa (IFN-α) causes depressive-like behavior by downregulating serotonin 1A (5-HT1A) receptors and increasing cellular apoptosis. Activating 5-HT1A receptors can alleviate these effects.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Hepatology

Background:

  • Hepatitis C virus (HCV) treatment with Interferon-alfa (IFN-α) can induce depressive-like behaviors, limiting its therapeutic use, particularly in patients with pre-existing psychiatric conditions.
  • Serotonin 1A (5-HT1A) receptors and cellular apoptosis are implicated in the mechanisms underlying depression.

Purpose of the Study:

  • To investigate the impact of IFN-α on 5-HT1A receptor modulation and cellular apoptosis in mice.
  • To explore the relationship between IFN-α-induced depressive-like behavior, 5-HT1A receptor function, and apoptosis.

Main Methods:

  • C57BL/6J mice were administered IFN-α to induce "depressive-like" behavior.
  • Behavioral tests included the forced swim test, tail suspension test, and sucrose preference test.
  • Changes in 5-HT1A receptor expression, cleaved caspase-3, and Bax/Bcl-2 ratio were analyzed. The effects of 5-HT1A receptor agonist 8-OH-DPAT and imipramine were evaluated.

Main Results:

  • IFN-α administration induced "depressive-like" behavior in mice.
  • Depressive mice showed downregulated 5-HT1A receptors and upregulated cleaved caspase-3 and Bax/Bcl-2 ratio, indicating increased cellular apoptosis.
  • The 5-HT1A receptor agonist 8-OH-DPAT blocked these molecular changes and ameliorated depressive-like behavior, while imipramine only ameliorated behavior.

Conclusions:

  • Repeated IFN-α injections provoke "depressive-like" behavior in mice, mediated by cellular apoptosis.
  • Activation of the 5-HT1A receptor pathway is a key mechanism in mitigating IFN-α-induced depression.
  • Targeting 5-HT1A receptors may offer a therapeutic strategy for IFN-α-associated depression in HCV patients.